U.S. Semiconductors Stock News

NYSE:CR
NYSE:CRMachinery

Assessing Crane (CR) Valuation As Acquisition And Earnings Expectations Shape Market Pricing

Crane stock snapshot and recent performance Crane (CR) gives investors exposure to engineered industrial products across aerospace and process flow markets, with shares last closing at US$182.05. The stock is up about 6% over the past month and down roughly 9% over the past 3 months. See our latest analysis for Crane. Recent trading points to fading short term momentum, with the share price down about 9.4% over three months. However, total shareholder returns of 7.1% over one year and very...
NasdaqGS:THRM
NasdaqGS:THRMAuto Components

Gentherm (THRM) Valuation Check After Recent Share Price Rebound And Mixed Long Term Returns

Gentherm stock snapshot after recent trading move Gentherm (THRM) has caught investor attention after a recent rebound in its share price, with the stock up 17.4% over the past month and 14.1% over the past 3 months based on provided data. See our latest analysis for Gentherm. The recent strength in Gentherm’s share price, including a 2.57% 1 day share price return and 8.67% over 7 days, comes against a mixed backdrop where the year to date share price return is down 3.39% but the 1 year...
NYSE:NEE
NYSE:NEEElectric Utilities

Is It Time To Reassess NextEra Energy (NEE) After Its Recent Share Price Pullback

If you have ever wondered whether NextEra Energy at around US$83.66 reflects a fair price or a stretch, this is a good moment to step back and test what the current tag might really mean for long term investors. The stock has slipped around 5.5% over the past week and about 13.7% over the past month, yet it is still up 3.4% year to date and around 21.8% over the past year, which can change how the risk and reward trade off feels right now. Recent news coverage has largely focused on the...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Assessing Capricor Therapeutics (CAPR) Valuation After Recent Share Price Cooling And Phase 3 Progress

Capricor Therapeutics stock reaction and recent performance snapshot Capricor Therapeutics (CAPR) has drawn investor attention after recent trading moves, with the stock closing at US$28.53, as ongoing phase 3 work on its lead Duchenne muscular dystrophy therapy continues to shape sentiment. See our latest analysis for Capricor Therapeutics. Short term, the stock has cooled after its recent phase 3 developments, with the 1 day share price return down 4.8% and the 1 month share price return...
NYSE:RYN
NYSE:RYNSpecialized REITs

Rayonier’s Early PotlatchDeltic Merger Puts Valuation And Synergies In Focus

Rayonier (NYSE:RYN) has completed its merger with PotlatchDeltic earlier than initially planned. The combined timberland REIT is targeting substantial operational synergies across its enlarged portfolio. The deal reinforces Rayonier's focus on sustainable timberland management and expands its operating footprint. For shareholders, the timing of this merger comes after a challenging few years for NYSE:RYN, with the stock down 11.7% over 3 years and 22.9% over 5 years. The current share price...
NasdaqGS:ADSK
NasdaqGS:ADSKSoftware

Is Autodesk (ADSK) Offering Value After A 16% One Year Share Price Decline?

If you are wondering whether Autodesk at around US$248 a share is offering fair value or whether you are paying up for quality, this article breaks down what the current price may be implying. The stock is up 3.0% over the past week and 1.6% over the past month, but year to date it is down 13.5% and the 1 year return is a decline of 16.0%. This can change how investors think about both upside potential and risk. Recent headlines around Autodesk have focused on its role in core design...
NYSE:RSG
NYSE:RSGCommercial Services

Is Republic Services (RSG) Still Attractive After A 21% One Year Share Price Decline

If you are wondering whether Republic Services at around US$200.83 is still a solid deal or starting to look expensive, the key is to understand what the current price actually reflects. The stock is down 3.9% over the past week, 2.8% over the last month, 4.5% year to date, and 21.3% over the past year, although the 3 year and 5 year returns of 44.7% and 97.2% tell a different, longer term story. Recent market attention has focused on Republic Services as part of broader interest in...
NYSE:SHW
NYSE:SHWChemicals

Is It Time To Reassess Sherwin-Williams (SHW) After Its Recent Share Price Slide?

Investors may be wondering if Sherwin-Williams at around US$294.86 is a bargain or just fairly priced, especially after a choppy run for the stock. The share price is down about 4.6% over the past week, 7.3% over the past month, and 10.1% year to date, with a 16.3% decline over the last year, but a gain of 26.3% over three years and 9.8% over five years. These mixed returns have kept Sherwin-Williams on many watchlists, with investors weighing long term prospects against recent share price...
NYSE:HRB
NYSE:HRBConsumer Services

A Look At H&R Block (HRB) Valuation After A Recent Share Price Rebound

What recent performance signals for H&R Block (HRB) H&R Block (HRB) has drawn fresh attention after a strong month, with the stock up about 27% over that period and about 26% over the past 3 months, against weaker year-to-date and 1-year returns. See our latest analysis for H&R Block. The recent 30 day share price return of 26.62% and 90 day return of 25.62% sit against a weaker year to date share price return and a 1 year total shareholder return that declined 29.73%, while the 3 and 5 year...
NYSE:ABT
NYSE:ABTMedical Equipment

Is Abbott Laboratories (ABT) Now Attractive After A 33% One Year Share Price Slide

Wondering whether Abbott Laboratories at US$87.78 is starting to look interesting on valuation, or if the market still sees more downside risk than upside. The stock is up 0.4% over the last week but down 1.9% over the last 30 days, with year to date and 1 year returns declining 29.3% and 32.9% respectively, which puts recent moves in sharp contrast to longer term performance. These returns have kept Abbott Laboratories in focus alongside ongoing sector wide interest in healthcare companies,...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Assessing Affirm Holdings (AFRM) Valuation After Its Strong 90 Day Share Price Performance

Why Affirm Holdings (AFRM) Is Back On Investor Radars Affirm Holdings (AFRM) has drawn fresh attention after a strong past 3 months for the stock, prompting investors to reassess how its buy now, pay later model fits into diversified financials exposure. See our latest analysis for Affirm Holdings. At a share price of $72.91, Affirm’s recent run includes a 52.44% 90 day share price return and a 37.83% 1 year total shareholder return. Year to date momentum has eased slightly, hinting at...
NYSE:DHR
NYSE:DHRLife Sciences

What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders

In recent days, SCIEX, a Danaher company, announced platform-wide upgrades to its accurate mass ZenoTOF line and unveiled the novus V55 next-generation triple quadrupole mass spectrometer, both coupled with new AI-enabled SCIEX OS 5.0 software to streamline complex omics and high-throughput laboratory workflows. By combining higher sensitivity instruments, broader front-end compatibility, and AI-supported workflow tools, these launches deepen Danaher’s presence in data-intensive life science...
NasdaqGS:VFS
NasdaqGS:VFSAuto

VinFast Targets Level 4 Autonomy To Reframe Risky Growth Story

VinFast Auto (NasdaqGS:VFS) has announced an alliance with NVIDIA and Autobrains to build a Level 4 autonomous driving platform tailored for Southeast Asia. The collaboration focuses on cost efficient, scalable self driving technology using NVIDIA's validated computing platform and Autobrains' specialized AI. The partners aim to address the complex driving conditions common across Southeast Asian roads and cities. For investors tracking VinFast Auto, the announcement comes with the stock at...
NYSE:FHN
NYSE:FHNBanks

A Look At First Horizon (FHN) Valuation After Recent Share Price Softness

Recent performance snapshot First Horizon (FHN) has drawn investor attention after a mixed performance in recent periods, with the stock down about 5.1% over the past month but slightly positive over the past 3 months. For context, the company reports revenue of US$3,429 million and net income of US$1,000 million. This gives investors a sense of current scale and profitability as they weigh the recent share price moves. See our latest analysis for First Horizon. While the share price has...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

A Look At Brighthouse Financial (BHF) Valuation As The Aquarian Deal And Earnings Path Take Shape

What Brighthouse Financial’s latest figures tell you Brighthouse Financial (BHF) is back on radar after its recent trading session, with the stock closing at US$62.66 and showing mixed short term returns alongside a longer term track record that some investors are reassessing. See our latest analysis for Brighthouse Financial. While the latest move in Brighthouse Financial’s share price was small, the stock’s 4.82% 90 day share price return, alongside a 46.30% three year total shareholder...
NYSE:FIX
NYSE:FIXConstruction

Is It Too Late To Consider Comfort Systems USA (FIX) After A 78% Year To Date Surge

Wondering whether Comfort Systems USA at around US$1,787.88 is still reasonably priced after a strong run, or if the stock is now baking in too much optimism. The share price is up 78.1% year to date and has delivered a very large gain over 5 years, even though it declined 2.2% over the past week and fell 4.2% over the past month. Recent coverage has focused on Comfort Systems USA as a construction and building services contractor, with attention on how its role in mechanical and electrical...
NYSE:KVYO
NYSE:KVYOSoftware

Intapp And 2 Additional Stocks That May Be Priced Below Estimated Value

The United States market has shown impressive performance, rising 1.6% over the last week and climbing 28% in the past year, with earnings forecasted to grow by 17% annually. In light of these conditions, identifying stocks that may be priced below their estimated value can offer opportunities for investors seeking potential growth at a reasonable cost.
NYSE:TPC
NYSE:TPCConstruction

3 Growth Companies With High Insider Ownership And Up To 114% Earnings Growth

The United States market has shown robust performance, climbing 1.6% in the last 7 days and up 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often signal strong confidence from those closest to the business and can offer significant potential for earnings growth.
OTCPK:ELTP
OTCPK:ELTPPharmaceuticals

Top Penny Stocks To Watch In June 2026

The market has shown positive momentum, with a 1.6% increase over the last week and a 28% climb in the past year, while earnings are projected to grow significantly in the coming years. In this context, identifying stocks with strong financial health is crucial for navigating potential growth opportunities. Penny stocks—though an older term—still represent viable options for investors seeking to tap into smaller or newer companies that might offer substantial returns when backed by solid...
NasdaqCM:COFS
NasdaqCM:COFSBanks

ChoiceOne Financial Services And 2 Other Top Dividend Stocks To Consider

The United States market has shown robust performance recently, with a 1.6% rise over the past week and a remarkable 28% increase in the last year, alongside an optimistic forecast for annual earnings growth of 17%. In such a thriving environment, dividend stocks like ChoiceOne Financial Services can be attractive options for investors seeking steady income and potential capital appreciation.
NasdaqGS:TRIP
NasdaqGS:TRIPInteractive Media and Services

Is Tripadvisor (TRIP) Using AI Ambitions To Quietly Redraw Its Competitive Moat?

Recently, Wedbush upgraded Tripadvisor’s rating to Outperform, citing confidence in corporate governance changes, activist investor involvement, and a review of TheFork alongside expanded AI efforts using its extensive travel data and OpenAI collaborations. This endorsement highlights how Tripadvisor’s push into artificial intelligence and portfolio review could reshape how travelers discover, plan, and book experiences on its platforms. With Wedbush emphasizing Tripadvisor’s expanding AI...
NYSE:LNN
NYSE:LNNMachinery

The Bull Case For Lindsay (LNN) Could Change Following Revenue Miss And MENA Project Risks – Learn Why

Lindsay (NYSE:LNN) recently reported a weak quarter, with revenues falling 15.7% year on year and missing analysts’ expectations by 4.2%. While the company has begun shipping a large project into the Middle East North Africa region, management is emphasizing employee safety amid geopolitical risks, highlighting operational complexities beyond the headline revenue shortfall. With this context in mind, we’ll examine how the revenue decline and earnings miss shape Lindsay’s investment narrative...
NasdaqGS:CGNT
NasdaqGS:CGNTSoftware

Cognyte Software (CGNT) Is Up 21.2% After New APAC National Security AI Upgrade Deal - What's Changed

Cognyte Software announced in May 2026 that it entered into an approximately US$5,000,000 upgrade agreement with a long-standing national security agency customer in the Asia-Pacific region, enhancing the agency’s investigative analytics environment with newer AI-driven capabilities for faster, more efficient intelligence operations. The deal highlights how national security agencies are increasingly relying on investigative analytics to manage complex, data-heavy intelligence workflows,...
NasdaqGS:MDLN
NasdaqGS:MDLNMedical Equipment

What Medline (MDLN)'s Canadian Prime Vendor Deal and Equity Raise Mean For Shareholders

In May 2026, Medline completed a US$2.68 billion follow-on offering of 72,554,594 Class A shares at US$37 each, while also expanding its animal health portfolio with custom spay/neuter surgical packs and supporting shelters like Pensacola Humane Society in scaling high-volume procedures. Medline Canada’s first Prime Vendor agreement with Mohawk Medbuy marks the company’s initial Prime Vendor foothold outside the US, highlighting how its supply chain capabilities and product innovation are...